The study was a single-center, open-label trial. Treatment consisted of 6 weekly subcutaneous injections (sc) of pentosan (2mg/kg). Patients were clinically assessed at entry and 1 to 8 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback